Key Highlights of the Report: Ø Regulatory Landscape: The report provides an in-depth analysis of the regulatory environment governing compounding pharmacies, highlighting recent changes in the U.S. Pharmacopeia (USP) guidelines and the impact of FDA oversight on compounding practices. Ø Technological Advancements: Advances in pharmaceutical compounding technologies,...